Dashboard
Portfolios
Watchlist
Community
Discover
Screener
Narratives
Your Valuation
Community
/
United States
/
Healthcare
Create a narrative
Solventum Community
NYSE:SOLV Community
1
Narratives
written by author
0
Comments
on narratives written by author
36
Fair Values set
on narratives written by author
Community Investing Ideas
Solventum
Popular
Undervalued
Overvalued
Solventum
AN
AnalystConsensusTarget
Consensus Narrative from 7 Analysts
New VAC Product And AI Will Simplify Procedures
Key Takeaways Streamlining operations and divesting non-core assets are expected to improve margins, reduce leverage, and focus growth efforts on core segments. Innovations in product offerings and AI-driven technology aim to enhance efficiency, drive revenue growth, and boost net margins.
View narrative
US$84.86
FV
15.3% undervalued
intrinsic discount
1.28%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
23
users have followed this narrative
6 days ago
author updated this narrative
Your Valuation for
SOLV
SOLV
Solventum
Your Fair Value
US$
Current Price
US$71.86
45.4% overvalued
intrinsic discount
Growth estimate over
Annual revenue growth rate
5 Years
time period
%/yr
Decrease
Increase
Past
Future
0
9b
2015
2018
2021
2024
2025
2027
2030
Revenue US$9.0b
Earnings US$407.2m
Advanced
Set Fair Value